Caricamento...
Body Composition and Leptin/Ghrelin Levels during Lenvatinib for Thyroid Cancer
Weight loss is one of the most frequent adverse events during treatment with multikinase inhibitors, but scanty data are available on its extent and characteristics. This is the first assessment of the body composition by bioelectrical impedance analysis and of circulating leptin and ghrelin levels,...
Salvato in:
| Pubblicato in: | Eur Thyroid J |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
S. Karger AG
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7024882/ https://ncbi.nlm.nih.gov/pubmed/32071896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000504048 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|